Labeler
BluePoint Laboratories NDC Codes
BluePoint Laboratories lists 349 finished drug products in the FDA NDC Directory under NDC labeler code 68001.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Nadolol, Dasatinib, doxorubicin hydrochloride, Metoprolol Succinate, Aprepitant, Zenatane, Decitabine, Labetalol Hydrochloride, Cyclophosphamide, Fluoxetine, Etoposide, Haloperidol decanoate, leucovorin calcium, Mitomycin
- Active ingredients
- Enoxaparin sodium, Nicotine, Nadolol, Dasatinib, Doxorubicin hydrochloride, Metoprolol succinate, Isotretinoin, Decitabine, Labetalol hydrochloride, Cyclophosphamide, Aprepitant, Fluoxetine hydrochloride
- NDC labeler codes
- 68001
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Enoxaparin sodium 100 mg/mL; Etoposide 20 mg/mL; Decitabine 50 mg/10mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Nadolol 20 mg/1; Nadolol 40 mg/1; Nadolol 80 mg/1; Enoxaparin sodium 150 mg/mL; Fluorouracil 50 mg/mL; Cisplatin 1 mg/mL; Palonosetron hydrochloride .25 mg/5mL; Labetalol hydrochloride 300 mg/1; Paclitaxel 6 mg/mL; Teriparatide 250 ug/mL; Cyclophosphamide 500 mg/25mL; Cyclophosphamide 1 g/50mL; Cyclophosphamide 2 g/100mL
- Dosage forms
- Injection, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Patch, Extended release, Capsule, Injection, Solution, Tablet, Extended release, Capsule, Gelatin coated, Injection, Solution, Concentrate, Injection, Suspension, Liposomal, Injection, Powder, For solution, Injectable, Liposomal, Solution, Tablet, Film coated, Extended release, Kit, Patch, Injection, Powder, Lyophilized, For suspension, Gel, Spray, Capsule, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Transdermal, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- beta-Adrenergic Blocker, Nucleoside Metabolic Inhibitor, Kinase Inhibitor, Low Molecular Weight Heparin, Cholinergic Nicotinic Agonist, Anthracycline Topoisomerase Inhibitor, Serotonin Reuptake Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Retinoid, Microtubule Inhibitor, Topoisomerase Inhibitor, Typical Antipsychotic, Folate Analog, Alkylating Drug, Anti-epileptic Agent, Mood Stabilizer, Nonsteroidal Anti-inflammatory Drug, Aminoketone, Bisphosphonate, Platinum-based Drug, Serotonin-3 Receptor Antagonist, Parathyroid Hormone Analog, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytochrome P450 17A1 Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Corticosteroid, Opioid Antagonist, Vitamin B12, Estrogen Receptor Antagonist, Osmotic Laxative, Potassium Salt
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 131 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Decitabine | Decitabine 50 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-713 | 68001-0713-37 | — |
| Palonosetronpalonosetron hydrochloride | Palonosetron hydrochloride .25 mg/5mL | InjectionIntravenous | 68001-708 | 68001-0708-25 | — |
| doxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | 68001-706 | 68001-0706-36 | — |
| doxorubicin hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injection, Suspension, LiposomalIntravenous | 68001-707 | 68001-0707-26 | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 300 mg/1 | TabletOral | 68001-702 | 68001-0702-0068001-0702-03 | — |
| Nicotine Transdermal System Patch Step 3nicotine transdermal system patch | Nicotine 7 mg/24h | Patch, Extended releaseTransdermal | 68001-697 | 68001-0697-8868001-0697-90 | — |
| Nicotine Transdermal System Patch Step 2nicotine transdermal system patch | Nicotine 14 mg/24h | Patch, Extended releaseTransdermal | 68001-698 | 68001-0698-8868001-0698-90 | — |
| Nicotine Transdermal System Patch Step 1nicotine transdermal system patch | Nicotine 21 mg/24h | Patch, Extended releaseTransdermal | 68001-699 | 68001-0699-8868001-0699-9068001-0699-91 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 68001-703 | 68001-0703-36 | — |
| Doxorubicin Hydrochloride | Doxorubicin hydrochloride 2 mg/mL | Injectable, LiposomalIntravenous | 68001-704 | 68001-0704-26 | — |
| Paclitaxel | Paclitaxel 6 mg/mL | InjectionIntravenous | 68001-705 | 68001-0705-27 | — |
| Teriparatide | Teriparatide 250 ug/mL | InjectionSubcutaneous | 68001-693 | 68001-0693-76 | — |
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | 68001-694 | 68001-0694-27 | — |
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | 68001-695 | 68001-0695-32 | — |
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | 68001-696 | 68001-0696-32 | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 100 mg/1 | TabletOral | 68001-700 | 68001-0700-0068001-0700-03 | — |
| Labetalol Hydrochloride | Labetalol hydrochloride 200 mg/1 | TabletOral | 68001-701 | 68001-0701-0068001-0701-03 | — |
| Metoprolol Succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | 68001-686 | 68001-0686-0068001-0686-03 | — |
| Metoprolol Succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | 68001-687 | 68001-0687-00 | — |
| Metoprolol Succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | 68001-684 | 68001-0684-0068001-0684-03 | — |
| Metoprolol Succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | 68001-685 | 68001-0685-0068001-0685-03 | — |
| Nadolol | Nadolol 20 mg/1 | TabletOral | 68001-690 | 68001-0690-00 | — |
| Nadolol | Nadolol 40 mg/1 | TabletOral | 68001-691 | 68001-0691-00 | — |
| Nadolol | Nadolol 80 mg/1 | TabletOral | 68001-692 | 68001-0692-00 | — |
| Aprepitant | Aprepitant 125 mg/1 | CapsuleOral | 68001-668 | 68001-0668-19 | — |
| Aprepitant | — | Kit | 68001-669 | 68001-0669-15 | — |
| Aprepitant | Aprepitant 40 mg/1 | CapsuleOral | 68001-666 | 68001-0666-0168001-0666-17 | — |
| Aprepitant | Aprepitant 80 mg/1 | CapsuleOral | 68001-667 | 68001-0667-0168001-0667-19 | — |
| Fluoxetine | Fluoxetine hydrochloride 40 mg/1 | CapsuleOral | 68001-672 | 68001-0672-0068001-0672-0368001-0672-04 | — |
| Fluoxetine | Fluoxetine hydrochloride 20 mg/1 | CapsuleOral | 68001-671 | 68001-0671-0068001-0671-08 | — |
| Zenataneisotretinoin | Isotretinoin 10 mg/1 | Capsule, Gelatin coatedOral | 68001-652 | 68001-0652-17 | — |
| Zenataneisotretinoin | Isotretinoin 20 mg/1 | Capsule, Gelatin coatedOral | 68001-653 | 68001-0653-17 | — |
| Zenataneisotretinoin | Isotretinoin 40 mg/1 | Capsule, Gelatin coatedOral | 68001-655 | 68001-0655-17 | — |
| Zenataneisotretinoin | Isotretinoin 30 mg/1 | Capsule, Gelatin coatedOral | 68001-654 | 68001-0654-17 | — |
| Dasatinib | Dasatinib 140 mg/1 | Tablet, Film coatedOral | 68001-665 | 68001-0665-04 | — |
| Fluoxetine | Fluoxetine hydrochloride 10 mg/1 | CapsuleOral | 68001-670 | 68001-0670-0068001-0670-08 | — |
| Olopatadine Hydrochloride | Olopatadine hydrochloride 2 mg/mL | SolutionOphthalmic | 68001-674 | 68001-0674-92 | — |
| Dasatinib | Dasatinib 80 mg/1 | Tablet, Film coatedOral | 68001-663 | 68001-0663-04 | — |
| Etoposide | Etoposide 20 mg/mL | Injection, Solution, ConcentrateIntravenous | 68001-681 | 68001-0681-25 | — |
| Etoposide | Etoposide 20 mg/mL | Injection, Solution, ConcentrateIntravenous | 68001-682 | 68001-0682-26 | — |
| Etoposide | Etoposide 20 mg/mL | Injection, Solution, ConcentrateIntravenous | 68001-683 | 68001-0683-27 | — |
| Dasatinib | Dasatinib 20 mg/1 | Tablet, Film coatedOral | 68001-660 | 68001-0660-06 | — |
| Dasatinib | Dasatinib 70 mg/1 | Tablet, Film coatedOral | 68001-662 | 68001-0662-06 | — |
| Dasatinib | Dasatinib 50 mg/1 | Tablet, Film coatedOral | 68001-661 | 68001-0661-06 | — |
| Dasatinib | Dasatinib 100 mg/1 | Tablet, Film coatedOral | 68001-664 | 68001-0664-04 | — |
| Abirateroneabiraterone acetate | Abiraterone acetate 500 mg/1 | TabletOral | 68001-673 | 68001-0673-06 | — |
| Fosaprepitant | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-675 | 68001-0675-25 | — |
| Eribulin Mesylate | Eribulin mesylate .5 mg/mL | SolutionIntravenous | 68001-656 | 68001-0656-41 | — |
| Lidocaine Pain Relieving Patchlidocaine 4% | Lidocaine 40 mg/g | PatchTopical | 68001-625 | 68001-0625-9368001-0625-95 | — |
| Paclitaxel protein-bound particles for injectable suspension (albumin-bound)paclitaxel | Paclitaxel 100 mg/20mL | Injection, Powder, Lyophilized, For suspensionIntravenous | 68001-651 | 68001-0651-37 | — |
BluePoint Laboratories: common questions
- What is BluePoint Laboratories's NDC labeler code?
- 68001. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for BluePoint Laboratories?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.